Subcutaneous apomorphine in Parkinson's disease.
作者信息
Pollak P, Champay A S, Hommel M, Perret J E, Benabid A L
出版信息
J Neurol Neurosurg Psychiatry. 1989 Apr;52(4):544. doi: 10.1136/jnnp.52.4.544.
Abstract
摘要
相似文献
1
Subcutaneous apomorphine in Parkinson's disease.帕金森病中的皮下注射阿扑吗啡
J Neurol Neurosurg Psychiatry. 1989 Apr;52(4):544. doi: 10.1136/jnnp.52.4.544.
2
Apomorphine infusion and the long-duration response to levodopa in advanced Parkinson's disease.阿扑吗啡输注与晚期帕金森病对左旋多巴的长期反应
Clin Neuropharmacol. 2003 May-Jun;26(3):151-5. doi: 10.1097/00002826-200305000-00009.
3
Comparison of motor response to apomorphine and levodopa in Parkinson's disease.帕金森病中阿扑吗啡与左旋多巴运动反应的比较。
J Neurol Neurosurg Psychiatry. 1990 Nov;53(11):1004-7. doi: 10.1136/jnnp.53.11.1004.
4
Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.皮下注射阿扑吗啡：关于其在帕金森病中应用的循证综述
Drugs Aging. 2004;21(11):687-709. doi: 10.2165/00002512-200421110-00001.
5
The clinical use of apomorphine in Parkinson's disease.阿扑吗啡在帕金森病中的临床应用。
J Neurol. 1992 Aug;239(7):389-93. doi: 10.1007/BF00812157.
6
[Intermittent apomorphine injections as rescue therapy for advanced Parkinson's disease. Consensus statement].[间歇性阿扑吗啡注射作为晚期帕金森病的抢救治疗。共识声明]
Nervenarzt. 2008 Apr;79(4):475-9. doi: 10.1007/s00115-007-2391-0.
7
Side-effects of subcutaneous apomorphine in Parkinson's disease.帕金森病中皮下注射阿扑吗啡的副作用。
Lancet. 1989 Mar 11;1(8637):566. doi: 10.1016/s0140-6736(89)90116-5.
8
Sublingual apomorphine solution in Parkinson's disease.帕金森病中的舌下阿扑吗啡溶液
Med J Aust. 1991 Sep 16;155(6):371-4. doi: 10.5694/j.1326-5377.1991.tb101311.x.
9
Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease.持续皮下注射阿扑吗啡用于帕金森病左旋多巴诱导的剂末异动症的长期治疗
J Neurol Neurosurg Psychiatry. 1998 May;64(5):573-6. doi: 10.1136/jnnp.64.5.573.
10
Beginning-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease.帕金森病患者急性服用左旋多巴和阿扑吗啡后出现的起始剂量运动功能恶化。
J Neurol Neurosurg Psychiatry. 1992 Nov;55(11):1024-6. doi: 10.1136/jnnp.55.11.1024.
引用本文的文献
1
Dopamine agonists in the treatment of Parkinson's disease: the show must go on.多巴胺激动剂治疗帕金森病：好戏还在后头。
J Neural Transm (Vienna). 2024 Dec;131(12):1471-1480. doi: 10.1007/s00702-024-02825-8. Epub 2024 Sep 11.
2
Continuous Subcutaneous Infusion Delivery of Apomorphine in Parkinson's Disease: A Systematic Review.阿朴吗啡持续皮下输注治疗帕金森病：系统评价。
Mov Disord Clin Pract. 2023 Jun 26;10(9):1253-1267. doi: 10.1002/mdc3.13810. eCollection 2023 Sep.
3
Therapies for Parkinson's disease and the gut microbiome: evidence for bidirectional connection.帕金森病的治疗与肠道微生物群：双向联系的证据
Front Aging Neurosci. 2023 May 30;15:1151850. doi: 10.3389/fnagi.2023.1151850. eCollection 2023.
4
Intermittent Apomorphine Use for off Period Rescue in Parkinson's Disease: A Pragmatic Review of over Three Decades of Clinical Experience.间歇性使用阿扑吗啡用于帕金森病“关”期急救：对三十多年临床经验的实用综述
Mov Disord Clin Pract. 2022 Oct 27;10(2):190-208. doi: 10.1002/mdc3.13593. eCollection 2023 Feb.
5
Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.阿扑吗啡在帕金森病中的应用的药理学研究进展：临床相关性。
Clin Drug Investig. 2018 Apr;38(4):287-312. doi: 10.1007/s40261-018-0619-3.
6
Advanced stages of PD: interventional therapies and related patient-centered care.帕金森病晚期：介入治疗及以患者为中心的相关护理。
J Neural Transm (Vienna). 2016 Jan;123(1):31-43. doi: 10.1007/s00702-015-1418-0. Epub 2015 Jul 3.
7
Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?阿扑吗啡与精神分裂症的多巴胺假说：一个困境？
J Psychiatry Neurosci. 2001 May;26(3):203-20.
8
Pharmacokinetic-pharmacodynamic relationships of apomorphine in patients with Parkinson's disease.帕金森病患者中阿扑吗啡的药代动力学-药效学关系。
Clin Pharmacokinet. 1999 Sep;37(3):257-71. doi: 10.2165/00003088-199937030-00004.
9
Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up.皮下注射阿扑吗啡治疗晚期帕金森病：长期随访
J Neurol Neurosurg Psychiatry. 1998 Nov;65(5):709-16. doi: 10.1136/jnnp.65.5.709.
10
Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease.持续皮下注射阿扑吗啡用于帕金森病左旋多巴诱导的剂末异动症的长期治疗
J Neurol Neurosurg Psychiatry. 1998 May;64(5):573-6. doi: 10.1136/jnnp.64.5.573.
本文引用的文献
1
Subcutaneous apomorphine in parkinsonian on-off oscillations.皮下注射阿扑吗啡治疗帕金森病的开关现象
Lancet. 1988 Feb 20;1(8582):403-6. doi: 10.1016/s0140-6736(88)91193-2.
2
Apomorphine infusion for motor fluctuations in Parkinson's disease.阿扑吗啡输注治疗帕金森病的运动波动
Lancet. 1987 Jun 13;1(8546):1376-7. doi: 10.1016/s0140-6736(87)90679-9.
3
Treatment of Parkinson's disease with aporphines. Possible role of growth hormone.阿朴啡类药物治疗帕金森病。生长激素的可能作用。
N Engl J Med. 1976 Mar 11;294(11):567-72. doi: 10.1056/NEJM197603112941101.
4
Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease.溴隐亭与外周多巴胺阻断剂联合用于治疗帕金森病。
Lancet. 1979 Mar 17;1(8116):570-2. doi: 10.1016/s0140-6736(79)91003-1.
Zotero 插件